Van Eygen 1989(b).
Methods | Trial III referred to above. Please see above for details. | |
Participants | ||
Interventions | ||
Outcomes | ||
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation? | Unclear risk | Details not given. |
Allocation concealment? | Unclear risk | Unclear |
Blinding? All outcomes | Unclear risk | "under double‐blind conditions, the medications being identical in appearance and taste" p670. Further details not given. |